Synthesis and study of controlled release of ibuprofen from the new acrylic type polymers.

New acrylic type polymeric systems having degradable ester bonds linked to ibuprofen were synthesized and evaluated as materials for drug delivery. Methacryloyloxy(2-hydroxy)propyl-4-isobutyl-alpha-methylphenyl acetate (MOPE), a new methacrylic derivative of ibuprofen in which the drug is separated from the methacrylic backbone by an oxy(2-hydroxy)propylene spacer arm and hydrolytically labile ester bond, was synthesized from reaction of glycidyl methacrylate with ibuprofen. The resulting drug containing monomer was copolymerized with methacrylamide, 2-hydroxyethyl methacrylate, N-vinyl-2-pyrrolidone or n-butyl methacrylate by free radical polymerization method in N,N-di-methylformamide (DMF) solution, utilizing azobisisobutyronitrile as initiator at the temperature range 65-70 degrees C. The obtained polymers were characterized by FT-IR, 1H NMR and 13C NMR spectroscopy. Gel permeation chromatography (GPC) was used for determination of average molecular weights of drug-polymer conjugates and showed that the polydispersity indices of the polymers are in the range of 1.9-2.3. Drug release studies were performed by hydrolysis in buffered solutions (pH 1 and 8) at 37 degrees C. Detection of hydrolysis by UV spectroscopy at selected interval showed that the drug can be released by selective hydrolysis of the ester bond at the side of drug moiety. The release profiles indicated that the hydrolytic behavior of polymeric prodrugs is strongly based on the hydrophilicity of polymer and the pH of the hydrolysis solution. The hydrophilic polymers containing ibuprofen were hydrolyzed in buffer solutions rather than the hydrophobic polymers.